The BDI has generated a strong portfolio of intellectual property, borne out of the diverse technical disciplines that come together in our research strands and Core Competencies. The BDI IP portfolio includes cutting edge devices and methodologies in microfluidics, molecular assays and signal detection, novel biomarkers of disease, and know-how pertaining to the generation and optimisation of customised antibodies.
A list of published patent applications generated from BDI research and development is available here.
The institute is governed by an Intellectual Property Model that is designed to maximise the capture and commercial exploitation of innovative technologies and to facilitate technology transfer to industry. The Model allows for flexible, bespoke agreements relating to IP ownership and exploitation rights.
For further information regarding the IP that is available for licencing, or to explore opportunities to partner with the BDI to develop or enhance existing IP, please contact:
Dr. Conor Burke - Associate Director (Commercialisation) / E: email@example.com / P: 01 700 8061